<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05023954</url>
  </required_header>
  <id_info>
    <org_study_id>262062version2</org_study_id>
    <nct_id>NCT05023954</nct_id>
  </id_info>
  <brief_title>mSEP: Testing of Physiological and Immune-metabolic Blood Markers for Maternal Sepsis</brief_title>
  <official_title>mSEP: Investigation of Maternal Immunity and Testing of Physiological and Immune-metabolic Blood Markers for Maternal Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiff University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cardiff and Vale University Health Board</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cardiff University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective observational cohort study investigating physiological parameters vs biological&#xD;
      markers of whole blood in septic and non-septic pregnant woman to predict systemic immune&#xD;
      health&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The altered physiology of pregnancy makes the signs and symptoms of sepsis less distinctive&#xD;
      in the pregnant population. This can lead to both over treatment (with antibiotics) and late&#xD;
      identification of sepsis. The progression of sepsis can be rapid in this population,&#xD;
      resulting in severe morbidity and mortality. The mortality associated with sepsis in the&#xD;
      general population is over 10%, while septic shock can increase this figure up to 30%. A&#xD;
      study looking at maternal mortality due to sepsis recognised that the time from the onset of&#xD;
      infection to death was less than 24 hours in 50% of patients. A review of the literature&#xD;
      shows that half of the fatal cases of maternal sepsis could have been prevented with early&#xD;
      detection of sepsis.&#xD;
&#xD;
      The unmet need is therefore a diagnostic bedside tool that can be performed on women&#xD;
      identified as high risk via physiological parameters. The tool needs to be quick and easy to&#xD;
      use whilst accurate at diagnosing sepsis.&#xD;
&#xD;
      Study Objectives&#xD;
&#xD;
      To evaluate the effectiveness of physiological parameters in predicting maternal sepsis.&#xD;
&#xD;
      To evaluate the effectiveness of alternative biomarkers in diagnosing maternal sepsis&#xD;
      including a genomic sepsis-test.&#xD;
&#xD;
      Investigation of the systemic immune health of women undergoing an uncomplicated pregnancy&#xD;
      and labour.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 12, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Positive predictive value of genomic sepsis-test biomarker in identifying participants with confirmed sepsis</measure>
    <time_frame>2 years</time_frame>
    <description>New genomic sepsis-test biomarker tested to see if it compares to clinically known biomarkers in identifying sepsis</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">330</enrollment>
  <condition>Sepsis</condition>
  <condition>Maternal Sepsis</condition>
  <condition>Maternal Sepsis During Labor</condition>
  <condition>SIRS</condition>
  <condition>Pregnancy; Infection</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <description>A longitudinal observational study looking at the pregnancy journey of 200 women Bloods taken for sepsis biomarkers including a genomic sepsis-test throughout the pregnancy journey</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <description>A consecutive collection of data from 100 pregnant women with suspected sepsis Bloods taken for Sepsis Biomarkers including a genomic sepsis-test throughout the sepsis episode</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Blood test</intervention_name>
    <description>Drop of blood for RNA and metabolic analysis</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      RNA analysis&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women attending University Hospital of Wales Cardiff for their pregnancy care&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Pregnant with viable pregnancy confirmed on ultrasound at dating scan and over 18 years of&#xD;
        age Able to provide informed consent (a translation service will be provided for women&#xD;
        where English is not the first language);&#xD;
&#xD;
        Women recruited into Cohort B will have deferred consent taken to avoid interference with&#xD;
        clinical care.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant woman under the age of 18 or wishing not to consent, withdrawing consent or&#xD;
             lacking capacity.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant Participants</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Ghazal, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiff University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Simran Sharma, MBBCH</last_name>
    <phone>07800885790</phone>
    <email>SharmaS44@cardiff.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Summia Zaher, MD</last_name>
    <email>ZaherS@cardiff.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sir Geraint Evans, Cardiff University</name>
      <address>
        <city>Cardiff</city>
        <zip>CF14 4ED</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Strang, PM</last_name>
      <phone>02920745534</phone>
      <email>StrangA@cardiff.acuk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 10, 2021</study_first_submitted>
  <study_first_submitted_qc>August 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2021</study_first_posted>
  <last_update_submitted>August 20, 2021</last_update_submitted>
  <last_update_submitted_qc>August 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Pregnancy Complications, Infectious</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

